Gilead’s Lenacapavir to Reach High-Burden Nations ‘At Cost’
Gilead’s Lenacapavir is set to revolutionise HIV prevention efforts, aiming to protect two million people across affected nations.
PEPFAR Funding Secure for Vital HIV Programmes
The United States Congress has spared the President’s Emergency Plan for AIDS Relief (PEPFAR), a cornerstone of global HIV/AIDS prevention for nearly two decades, from a potential $400 million budget cut.. The proposed reduction was part of the Trump administration’s wider “rescissions package.” This package aimed at clawing back $9.4 billion in previously approved federal…...
USAID Funding Cuts Could Trigger 14 Million Deaths by 2030
USAID funding cuts could cause 14m avoidable deaths by 2030, including 4.5m children under five, warns Lancet study.
Global Health: Understanding the WHO Pandemic Accord
Is the WHO Pandemic Accord a pathway to global health equity? Explore its significance in pandemic preparedness.